BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 27153743)

  • 1. Progestin-only contraception and thromboembolism: A systematic review.
    Tepper NK; Whiteman MK; Marchbanks PA; James AH; Curtis KM
    Contraception; 2016 Dec; 94(6):678-700. PubMed ID: 27153743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
    Tepper NK; Dragoman MV; Gaffield ME; Curtis KM
    Contraception; 2017 Feb; 95(2):130-139. PubMed ID: 27771476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestin-only contraceptives: effects on weight.
    Lopez LM; Ramesh S; Chen M; Edelman A; Otterness C; Trussell J; Helmerhorst FM
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008815. PubMed ID: 27567593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.
    Dragoman M; Curtis KM; Gaffield ME
    Contraception; 2016 Sep; 94(3):280-7. PubMed ID: 26272309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review.
    Horton LG; Simmons KB; Curtis KM
    Contraception; 2016 Dec; 94(6):590-604. PubMed ID: 27263039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestin-only contraceptives: effects on weight.
    Lopez LM; Edelman A; Chen M; Otterness C; Trussell J; Helmerhorst FM
    Cochrane Database Syst Rev; 2013 Jul; 7(7):CD008815. PubMed ID: 23821307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.
    Lopez LM; Grey TW; Stuebe AM; Chen M; Truitt ST; Gallo MF
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD003988. PubMed ID: 25793657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
    Carr BR; Ory H
    Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of hormonal contraceptives among women with migraine: A systematic review.
    Tepper NK; Whiteman MK; Zapata LB; Marchbanks PA; Curtis KM
    Contraception; 2016 Dec; 94(6):630-640. PubMed ID: 27153744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestogen-only contraceptive use among breastfeeding women: a systematic review.
    Phillips SJ; Tepper NK; Kapp N; Nanda K; Temmerman M; Curtis KM
    Contraception; 2016 Sep; 94(3):226-52. PubMed ID: 26410174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.
    Ramanadhan S; Hansen K; Henderson JT; Cohen MA; Paynter R; Edelman A
    Cochrane Database Syst Rev; 2023 May; 5(5):CD014908. PubMed ID: 37184292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between progestin-only contraceptive use and cardiometabolic outcomes: A systematic review and meta-analysis.
    Glisic M; Shahzad S; Tsoli S; Chadni M; Asllanaj E; Rojas LZ; Brown E; Chowdhury R; Muka T; Franco OH
    Eur J Prev Cardiol; 2018 Jul; 25(10):1042-1052. PubMed ID: 29745237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progestin-only contraceptives: effects on weight.
    Lopez LM; Edelman A; Chen-Mok M; Trussell J; Helmerhorst FM
    Cochrane Database Syst Rev; 2011 Apr; (4):CD008815. PubMed ID: 21491411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.
    Cohen MA; Edelman A; Paynter R; Henderson JT
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014908. PubMed ID: 36622724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Birth Control Pills and Thrombotic Risks: Differences of Contraception Methods with and without Estrogen.
    Rott H
    Hamostaseologie; 2019 Feb; 39(1):42-48. PubMed ID: 30669160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis.
    Mantha S; Karp R; Raghavan V; Terrin N; Bauer KA; Zwicker JI
    BMJ; 2012 Aug; 345():e4944. PubMed ID: 22872710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superficial venous disease and combined hormonal contraceptives: a systematic review.
    Tepper NK; Marchbanks PA; Curtis KM
    Contraception; 2016 Sep; 94(3):275-9. PubMed ID: 25835269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
    Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
    Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age.
    Cockrum RH; Soo J; Ham SA; Cohen KS; Snow SG
    Obstet Gynecol; 2022 Sep; 140(3):477-487. PubMed ID: 35926206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.